SS INNOVATIONS LAUNCHES SSI MANTRA, India’s First Medical Robotics Surgery System with a Human Pilot Study with 18 Procedures at RGCI.
SS Innovations has launched SSI Mantra (Multi-Arm Novel Tele Robotic Assistance) Surgical Robotic System), India’s first medical robotics surgery system. Priced in the range of Rs 4-5 crore, the SSI Mantra surgical robotic system can be utilised for all major surgical specialities including urology, general surgery, gynaecology, thoracic, cardiac, and head & neck surgery. The SSI Mantra System shall additionally have automated enabling technologies for coronary bypass and valve operations.
Despite decades of successful robotic-assisted surgeries globally that have positively impacted millions of patients, the access is scarce at large. The dominant current robotic system available from US and other developed economies is expensive and associated with a steep learning curve, resulting in the limited availability across the world of over six billion population.
Taking this up as a challenge and with a vision to offer minimally invasive robotic surgery solutions, Dr. Sudhir P. Srivastava and his team has launched the SSI MANTRA, almost at one-third of the price of the system globally. The pricing of Rs 4-5 crore would also include the AMC contract, informed Dr Srivastava. The AMC is very critical as though SSI Mantra has an average life span of 10 years, each component of the system will have certain life cycles and it is important to provide maintenance accordingly. Obviously, the modularity of the system helps and properly maintained it would support 15,000 hours of surgery.
The MANTRA system was recently utilised for the first in human pilot study at Rajiv Gandhi Cancer Institute (RGCI), where the surgeons successfully completed 18 complex Urology, Gynaecology and General Surgery procedures in less than a month. While robotic driven surgery first happened in India in 2001, first in AIIMS in 2006 and in RGCI in 2011, this is the first time a completely indigenous robotic surgery system has been developed in India. Dr Srivastava informed that till now 85 LoIs have been received for MANTRA including those from government hospitals. There are 72 systems currently available (2 more are coming) and about 400 surgeons with the relevant training to perform surgeries using the system.
“Robotics shall be the future of surgery, and my vision is to create a technologically advanced system that will be cost-effective, easy to use, and can be applied to all surgical specialities. Thus, benefitting most patients around the world. Compared to conventional surgery, robotic surgery results in smaller incisions, that reduces pain, scarring and leads to quicker recovery.” said Dr. Srivastava, one of the early pioneers in minimally invasive and robotic cardiac surgery.
Dr. Sudhir Rawal, Medical Director RGCI added, “The dedicated team of engineers and scientists at SS Innovations have been working hard under Dr. Srivastava’s guidance for the past few years to develop a cost-effective robotic surgical system. I congratulate them on this launch. I have been closely involved in the clinical trials myself, and the results have been outstanding.”